Australia markets closed

InterCure Ltd. (INCR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.5300-0.0200 (-0.78%)
At close: 04:00PM EDT
2.4900 -0.04 (-1.58%)
Pre-market: 06:57AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.5500
Open2.5000
Bid2.4900 x 200
Ask2.5800 x 200
Day's range2.2100 - 2.5500
52-week range0.9900 - 2.8680
Volume86,808
Avg. volume84,788
Market cap115.299M
Beta (5Y monthly)0.20
PE ratio (TTM)19.46
EPS (TTM)0.1300
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est32.79
  • Business Wire

    InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint

    NEW YORK & HERZLIYA, Israel, March 22, 2024--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company outside of North America, is thrilled to congratulate The Federal Republic of Germany for the passing of the "CannG" Cannabis Act, which is expected to take effect on April 1, 2024. On the backdrop of this monumental development, InterCure expects to launch a series of products in Germany in the coming months.

  • GlobeNewswire

    InterCure Provides an Update Regarding Nir Oz Facility

    NEW YORK, and HERZLIYA, Israel, Feb. 13, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in Israel and outside of North America, reports today that, further to the Company’s press release issued on October 17, 2023, in which the Company provided an update regarding the status of the security situation in Israel, and its impact on the Company and its employees, the Company is providing an additi

  • GlobeNewswire

    InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain

    NEW YORK, and HERZLIYA, Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in Israel and outside of North America, announced today that it has entered into a share purchase agreement (the “Agreement”) with the shareholders of Leon Pharm Ltd. (the “Sellers”, and “Leon Pharm”, respectively) to purchase Leon Pharm, a leading, Israel-based pharmacy chain specializing in dispensing med